SI-BONE Inc
Roxanne Simon was named Vice President of Program Management and Quality & Process Improvement by SI-BONE in October 2021. In this role, Ms. Simon is responsible for overseeing the Quality Assurance team and implementation and management of SI-BONE’s Quality Management System, overseeing the management of all projects in SI-BONE’s portfolio and being a champion of continuous improvement. Most recently, Ms. Simon served as Vice President of Project Management responsible for new product development projects as well as sustaining projects across the company. Prior to joining SI-BONE, Ms. Simon held positions in Engineering at Kyphon, Inc., Spinal Kinetics LLC, Epicor Medical, Inc. (acquired by St. Jude in 2004) and InnerDyne, Inc. (acquired by Tyco in 2000,). Additionally, she spent over 10 years in contract medical device development at Stellartech Research Corp and Hantel Technologies. Ms. Simon holds a BS in Bioengineering from the University of California, Berkeley and has over 30 years of experience in the medical device field.
This person is not in any offices
SI-BONE Inc
2 followers
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.